Immunotherapy News and Research

Latest Immunotherapy News and Research

Coveted BMJ award bestowed on The Clatterbridge Cancer Center

A coveted British Medical Journal award was recently bestowed on the Papillon Contact X-ray Brachytherapy team at the Clatterbridge Cancer Centre. The Cancer Care Team of the year category was won by the entry—Papillon for Rectal Cancer.

From Ariane Medical Systems 24 May 2018

Researchers to test two-pronged approach in humans to treat advanced colorectal cancer

For the first time in humans, researchers will test a two-pronged approach to treat advanced stage colorectal cancer, potentially increasing life expectancy.

22 May 2018

Treg infusions show promise in slowing progression of ALS

Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive and fatal disease.

21 May 2018

Researchers create tool to determine patient's response to immunotherapy drugs

Understanding that not all bladder cancers are the same, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have created a tool that may help them to uncover why only a fraction of patients respond to new immune-based treatments.

21 May 2018

Analysis of lymph node dissection shows no overall survival benefit in renal carcinoma patients

An analysis of lymph node dissection in renal cell carcinoma that has not spread to other organs indicates the procedure is often performed for stage 1 disease and shows no overall survival benefit.

21 May 2018

Study: Single surface protein can amplify multiple key pathways in acute myeloid leukemia

Researchers from the Albert Einstein College of Medicine in New York have discovered that a signaling protein elevated in patients with acute myeloid leukemia plays a much wider role in the disease than previously thought.

18 May 2018

Rutgers Cancer Institute nurses research various topics to enhance patient experience

From peer and patient education to addressing treatment side effects and other patient care needs, nurses at Rutgers Cancer Institute of New Jersey researched a number of topics with an aim of enhancing the patient experience.

18 May 2018

Alexo Therapeutics marks next significant milestone by initiating ALX148 combination cohorts

Alexo Therapeutics, a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint mechanism, today announced it has initiated ALX148 combination dosing with targeted antibody therapies in its Phase 1 clinical program in patients with advanced solid tumors and lymphoma.

17 May 2018

Obsidian Therapeutics presents preclinical data on regulated IL12 and IL15 programs

Obsidian Therapeutics, Inc., a biotechnology company dedicated to the development of next-generation cell and gene therapies with pharmacologic operating systems, today announced that the company presented preclinical data on its regulated IL12 and IL15 programs at the Annual Meeting of the American Society of Gene and Cell Therapy in Chicago, IL.

17 May 2018

Lowering blood cholesterol levels could enhance success of T-cell cancer immunotherapy

Cleveland Clinic researchers have demonstrated for the first time that lowering blood cholesterol levels could enhance the success of a specific type of T-cell immunotherapy in fighting cancer.

16 May 2018

Tufts University, BioLabs announce the opening of new biotech facility for life sciences entrepreneurs

Tufts University and BioLabs today announced the opening of Tufts Launchpad | BioLabs, a full-service biotech facility supporting high-potential, early-stage life sciences startup ventures in the Boston area.

16 May 2018

FDA clears Turnstone Biologics' IND for immunotherapy targeting HPV positive solid tumors

Turnstone Biologics today announced it has received U.S. Food and Drug Administration clearance of its Investigational New Drug Application for MG1-HPV for the treatment of patients with human papillomavirus positive solid tumors.

16 May 2018

Study finds distinct exhausted T cells that could have implications for fighting different diseases

The battle between the human immune system and long-term, persisting infections and other chronic diseases such as cancer results in a prolonged stalemate

16 May 2018

Genetic fixer-uppers could aid in predicting prognosis of patients with bladder cancer

Mutations in genes that help repair damage to DNA may aid in predicting the prognosis of patients with bladder and other related cancers, according to researchers.

15 May 2018

Researchers test new cancer research model that may reduce cost and speed up studies

A new model for improving how clinical trials are developed and conducted by bringing together academic cancer experts and pharmaceutical companies is being tested by research experts at The University of Texas MD Anderson Cancer Center.

15 May 2018

UAB-led clinical trial intends to find innovative treatment for multiple myeloma patients

Multiple myeloma is the second most common type of blood cancer in the United States, impacting more than 25,000 people each year and disproportionatly affecting African-American men.

15 May 2018

Researchers discover unique mechanism that regulates tumor growth in lung cancer

Lung cancer is the third most common type of cancer in Germany and the disease affects both men and women. However, immunotherapies are successful in only 20 percent of cases.

14 May 2018

Queen's University researchers receive MRC award to develop new treatment for pancreatic cancer

Queen's University Belfast researchers at the Centre for Cancer Research and Cell Biology alongside local company Fusion Antibodies plc have secured a prestigious Medical Research Council award to develop a new antibody drug for the treatment of pancreatic cancer.

11 May 2018

Researchers manipulate bacterial species in the gut using diet

Scientists from Stanford University School of Medicine have shown that by manipulating diet in a mouse model, it is possible to favor the engraftment of a specific bacterial strain over others.

10 May 2018

New case study shows CAR T therapy as viable option for AML patients

Chimeric Antigen Receptor T-cell therapy, also known as CAR T therapy, was named the biggest research breakthrough of 2017 by the American Society of Clinical Oncology. The personal gene therapy utilizes a patient's own immune cells to fight cancer.

9 May 2018

Immunotherapy News and Research

Latest Immunotherapy News and Research

Coveted BMJ award bestowed on The Clatterbridge Cancer Center

Researchers to test two-pronged approach in humans to treat advanced colorectal cancer

Treg infusions show promise in slowing progression of ALS

Researchers create tool to determine patient's response to immunotherapy drugs

Analysis of lymph node dissection shows no overall survival benefit in renal carcinoma patients

Study: Single surface protein can amplify multiple key pathways in acute myeloid leukemia

Rutgers Cancer Institute nurses research various topics to enhance patient experience

Alexo Therapeutics marks next significant milestone by initiating ALX148 combination cohorts

Obsidian Therapeutics presents preclinical data on regulated IL12 and IL15 programs

Lowering blood cholesterol levels could enhance success of T-cell cancer immunotherapy

Tufts University, BioLabs announce the opening of new biotech facility for life sciences entrepreneurs

FDA clears Turnstone Biologics' IND for immunotherapy targeting HPV positive solid tumors

Study finds distinct exhausted T cells that could have implications for fighting different diseases

Genetic fixer-uppers could aid in predicting prognosis of patients with bladder cancer

Researchers test new cancer research model that may reduce cost and speed up studies

UAB-led clinical trial intends to find innovative treatment for multiple myeloma patients

Researchers discover unique mechanism that regulates tumor growth in lung cancer

Queen's University researchers receive MRC award to develop new treatment for pancreatic cancer

Researchers manipulate bacterial species in the gut using diet

New case study shows CAR T therapy as viable option for AML patients

eBook: The Ultimate Guide to Successful Immunofluorescence eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Immunotherapy News and Research

Latest Immunotherapy News and Research

eBook: The Ultimate Guide to Successful Immunofluorescence eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in